Clinical trial
Description and Prognostic Evaluation of Four Biological Parameters of Blast…
NCT00188084 · University Hospital, Angers, Other · Unknown status
Key facts
| NCT number | NCT00188084 |
|---|---|
| Title | Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia |
| Official title | Analysis of Four Biological Parameters at Diagnosis of Adult Acute Lymphoblastic Leukaemia: DNA Index, Percentage of Cells in S-Phase, CD45 Fluorescence Index, and Protein P16: Prognostic Study in Patients Enrolled in a Multicentric Trial |
| Lead sponsor | University Hospital, Angers, Other |
| Collaborators | French Innovative Leukemia Organisation |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Adult Acute Lymphoblastic Leukemia |
| Intervention type | Procedure |
| Interventions | DNA Index, S-Phase%, CD45 expression, P16 metabolic way |
| Enrollment | 400 |
| Start date | Nov 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 28, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: